Jerome Salvani
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Resistance in Bacteria 2
-
- COVID-19 Clinical Research Studies 1
- Co-authors
- Simona Bratu (2 shared papers)John Quale (2 shared papers)David Landman (2 shared papers)Anthony M. George (1 shared paper)Alvin Oommen (2 shared papers)Priyanka Parmar (1 shared paper)Michael Joseph (1 shared paper)Rohan Maini (1 shared paper)
- Journals
- International Journal of Obesity (1 paper)Journal of Clinical Microbiology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)BMJ Open Diabetes Research & Care (1 paper)Clinics and Practice (1 paper)
- Partner nations
- United States
In The Last Decade
Jerome Salvani
5 papers receiving 256 citations
Peers
Comparison fields: 5 of 53
- Molecular Medicine 130
- Endocrinology 47
- Applied Microbiology and Biotechnology 12
- Infectious Diseases 81
- Clinical Biochemistry 28
Countries citing papers authored by Jerome Salvani
This map shows the geographic impact of Jerome Salvani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Salvani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Salvani more than expected).
Fields of papers citing papers by Jerome Salvani
This network shows the impact of papers produced by Jerome Salvani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Salvani. The network helps show where Jerome Salvani may publish in the future.
Co-authors
The 13 scholars most cited alongside Jerome Salvani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 112 | |
| 2 | 2005 | 73 | |
| 3 | 2009 | 67 | |
| 4 | 2011 | 6 | |
| 5 | 2022 | 4 |
About Jerome Salvani
Jerome Salvani is a scholar working on Molecular Medicine, Infectious Diseases, Pollution, Epidemiology and Public Health, Environmental and Occupational Health, having authored 5 papers that have together received 262 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (2 papers), COVID-19 Clinical Research Studies (1 paper), Antibiotic Use and Resistance (1 paper), Streptococcal Infections and Treatments (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Neonatal and Maternal Infections (1 paper) and Pharmaceutical and Antibiotic Environmental Impacts (1 paper). The work is most often cited by research in Molecular Medicine (130 citations), Endocrinology (47 citations), Applied Microbiology and Biotechnology (12 citations), Infectious Diseases (81 citations) and Clinical Biochemistry (28 citations). Jerome Salvani has collaborated with scholars based in United States. Frequent co-authors include Simona Bratu, John Quale, David Landman, Anthony M. George, Alvin Oommen, Priyanka Parmar, Michael Joseph, Rohan Maini, Igal Breitman and Pia Daniel. Their work appears in journals such as International Journal of Obesity, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, BMJ Open Diabetes Research & Care and Clinics and Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.